Steminent Biotherapeutics Inc.
7729
Rank in Stocks
#11835
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Share Price
$6.51
Last synced: 2026-11-10
Market Cap
$525.11M
Change (1 day)
6.22%
Change (1 year)
410.55%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Steminent Biotherapeutics Inc. (7729)
Category
Healthcare
EPS for Steminent Biotherapeutics Inc. (7729)
EPS as of September 2026 TTM: $-0.12
According to Steminent Biotherapeutics Inc.'s latest financial reports, its current EPS (TTM) is $-0.12. At the end of 2025 the company had an EPS of $-0.09, equal to its 2024 EPS of $-0.09.
EPS history for Steminent Biotherapeutics Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.12 | 36.22% |
| 2025 | $-0.09 | 8.67% |
| 2024 | $-0.09 | -8.47% |
| 2023 | $-0.09 | 50.96% |
| 2022 | $-0.06 | -50.71% |
| 2021 | $-0.13 | 260.80% |
| 2020 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -12,873.25% |
US
|
|
| $-7.07 | 5,666.72% |
US
|
|
| $-5.29 | 4,214.85% |
AU
|
|
| $12.88 | -10,605.79% |
BE
|
|
| $21.56 | -17,685.64% |
NL
|
Questions about Steminent Biotherapeutics Inc.'s earnings per share (EPS)
What is Steminent Biotherapeutics Inc.'s earnings per share (EPS)?
Steminent Biotherapeutics Inc.'s earnings per share (EPS) over the last twelve months is $-0.12, as of Sep 2026.
What was Steminent Biotherapeutics Inc.'s earnings per share (EPS) in 2025?
In 2025, Steminent Biotherapeutics Inc.'s earnings per share (EPS) was $-0.09, compared with $-0.09 in 2024.
How has Steminent Biotherapeutics Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Steminent Biotherapeutics Inc.'s earnings per share (EPS) was highest in 2020 ($-0.04) and lowest in 2021 ($-0.13).
How does Steminent Biotherapeutics Inc.'s earnings per share (EPS) compare with similar companies?
Steminent Biotherapeutics Inc.'s earnings per share (EPS) ($-0.12) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.